120 related articles for article (PubMed ID: 33046975)
21. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
22. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.
Yu F; Deng H; Yao H; Liu Q; Su F; Song E
Oncogene; 2010 Jul; 29(29):4194-204. PubMed ID: 20498642
[TBL] [Abstract][Full Text] [Related]
23. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
[TBL] [Abstract][Full Text] [Related]
24. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis.
Qian YW; Chen Y; Yang W; Fu J; Cao J; Ren YB; Zhu JJ; Su B; Luo T; Zhao XF; Dai RY; Li JJ; Sun W; Wu MC; Feng GS; Wang HY
Gastroenterology; 2012 Jun; 142(7):1547-58.e14. PubMed ID: 22387393
[TBL] [Abstract][Full Text] [Related]
25. miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression.
Chen X; Tan W; Li W; Li W; Zhu S; Zhong J; Shang C; Chen Y
J Cancer; 2019; 10(12):2745-2753. PubMed ID: 31258782
[No Abstract] [Full Text] [Related]
26. Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.
Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
Hepatology; 2011 Jan; 53(1):160-70. PubMed ID: 20979057
[TBL] [Abstract][Full Text] [Related]
27. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C
Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543
[TBL] [Abstract][Full Text] [Related]
29. LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma.
Zhang F; Yang C; Xing Z; Liu P; Zhang B; Ma X; Huang L; Zhuang L
Onco Targets Ther; 2019; 12():4013-4023. PubMed ID: 31190897
[No Abstract] [Full Text] [Related]
30. Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.
Lu AQ; Lv B; Qiu F; Wang XY; Cao XH
Oncol Rep; 2017 Apr; 37(4):2071-2078. PubMed ID: 28350139
[TBL] [Abstract][Full Text] [Related]
31. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
Guo XL; Wang HB; Yong JK; Zhong J; Li QH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
[TBL] [Abstract][Full Text] [Related]
32. MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway.
Zhang M; Zhang H; Hong H; Zhang Z
Am J Cancer Res; 2019; 9(4):765-778. PubMed ID: 31106002
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of EZH2 Attenuates Sorafenib Resistance by Targeting NOTCH1 Activation-Dependent Liver Cancer Stem Cells via NOTCH1-Related MicroRNAs in Hepatocellular Carcinoma.
Wang S; Cai L; Zhang F; Shang X; Xiao R; Zhou H
Transl Oncol; 2020 Mar; 13(3):100741. PubMed ID: 32092673
[TBL] [Abstract][Full Text] [Related]
34. In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis.
Fornari F; Pollutri D; Patrizi C; La Bella T; Marinelli S; Casadei Gardini A; Marisi G; Baron Toaldo M; Baglioni M; Salvatore V; Callegari E; Baldassarre M; Galassi M; Giovannini C; Cescon M; Ravaioli M; Negrini M; Bolondi L; Gramantieri L
Clin Cancer Res; 2017 Jul; 23(14):3953-3965. PubMed ID: 28096271
[No Abstract] [Full Text] [Related]
35. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X
Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA THOR promotes liver cancer stem cells expansion via β-catenin pathway.
Cheng Z; Lei Z; Yang P; Si A; Xiang D; Zhou J; Hüser N
Gene; 2019 Feb; 684():95-103. PubMed ID: 30359743
[TBL] [Abstract][Full Text] [Related]
37. A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
Kabir TD; Ganda C; Brown RM; Beveridge DJ; Richardson KL; Chaturvedi V; Candy P; Epis M; Wintle L; Kalinowski F; Kopp C; Stuart LM; Yeoh GC; George J; Leedman PJ
Hepatology; 2018 Jan; 67(1):216-231. PubMed ID: 28833396
[TBL] [Abstract][Full Text] [Related]
38. MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.
Wei X; Tang C; Lu X; Liu R; Zhou M; He D; Zheng D; Sun C; Wu Z
Oncotarget; 2015 Jul; 6(21):18389-405. PubMed ID: 26158762
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
40. Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment.
Zhang HL; Wang MD; Zhou X; Qin CJ; Fu GB; Tang L; Wu H; Huang S; Zhao LH; Zeng M; Liu J; Cao D; Guo LN; Wang HY; Yan HX; Liu J
Cancer Lett; 2017 Mar; 388():1-11. PubMed ID: 27894955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
